Eyedrop DPP-4 Inhibitors Proposed as Novel Non-Invasive Strategy for Early Diabetic Retinal Disease
Eyedrop Administration of DPP-4 Inhibitors: A New Strategy for Treating Early Stages of Diabetic Retinal Disease
Abstract
Eyedrop DPP-4 inhibitors are proposed as a non-invasive strategy to target early neurodegeneration in diabetic retinal disease, addressing an unmet need.